thrombotic thrombocytopenic purpura

Showing 1 - 24 of 24

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

TTP Patients: Italian Experience (ROSCAPLI)

Recruiting
  • Thrombotic Thrombocytopenic Purpura
  • Roma, Italy
    FPG
Mar 14, 2023

Thrombotic Thrombocytopenic Purpura Trial in Japan (Caplacizumab (ALX-0081), Plasma exchange (PE), Corticosteroid treatment

Completed
  • Thrombotic Thrombocytopenic Purpura
  • Caplacizumab (ALX-0081)
  • +3 more
  • Iruma-Gun, Japan
  • +11 more
Jan 30, 2023

Hereditary Thrombotic Thrombocytopenic Purpura

Recruiting
  • Thrombotic Thrombocytopenic Purpura
  • +4 more
  • Observation
  • Oklahoma City, Oklahoma
  • +6 more
Nov 1, 2022

Thrombotic Thrombocytopenic Purpura Trial (Aspirin tablet, Placebo)

Not yet recruiting
  • Thrombotic Thrombocytopenic Purpura
  • Aspirin tablet
  • Placebo
  • (no location specified)
Sep 30, 2022

Thrombotic Thrombocytopenic Purpura Trial (Caplacizumab, Corticosteroids, anti-CD20 antibody)

Not yet recruiting
  • Thrombotic Thrombocytopenic Purpura
  • (no location specified)
Aug 8, 2022

.German TTP-Registry (Thrombotic Thrombocytopenic Purpura)

Recruiting
  • Thrombotic Thrombocytopenic Purpura
    • Mainz, Germany
      University Hospital Mainz, Hematology
    May 20, 2022

    Thrombotic Thrombocytopenic Purpura Trial in Paris (Sulfate, Magnesium, Placebo - Concentrate)

    Active, not recruiting
    • Thrombotic Thrombocytopenic Purpura
    • Sulfate, Magnesium
    • Placebo - Concentrate
    • Paris, France
      Saint Louis hospital
    Oct 28, 2021

    Thrombotic Thrombocytopenic Purpura Trial in United States (rituximab)

    Completed
    • Thrombotic Thrombocytopenic Purpura
    • rituximab
    • Atlanta, Georgia
    • +3 more
    Aug 13, 2021

    The ConNeCT Study: Neurological Complications of TTP

    Recruiting
    • Thrombotic Thrombocytopenic Purpura
    • Questionnaires (including PHQ-9, TYM and SF-36)
    • Liverpool, United Kingdom
      Royal Liverpool University Hospital
    Aug 2, 2021

    Observational Study of the Use of octaplasLG®.

    Completed
    • Thrombotic Thrombocytopenic Purpura
    • Avignon, France
    • +13 more
    Mar 18, 2021

    Immune Thrombocytopenia, Thrombotic Thrombocytopenic Purpura Trial in Monterrey (Romiplostim, Rituximab, Dexamethasone)

    Unknown status
    • Immune Thrombocytopenia
    • Thrombotic Thrombocytopenic Purpura
    • Monterrey, Nuevo León, Mexico
      Servicio de Hematología, Hospital Universitario "Dr. José Eleute
    Oct 8, 2020

    Octaplas Adult TTP Trial

    Terminated
    • Thrombotic Thrombocytopenic Purpura
    • Octaplas
    • Standard Plasma
    • Manhasset, New York
    • +1 more
    Oct 10, 2019

    Thrombotic Microangiopathies, Thrombotic Thrombocytopenic Purpura Trial in Paris (Biological and imaging investigations)

    Completed
    • Thrombotic Microangiopathies
    • Thrombotic Thrombocytopenic Purpura
    • Biological and imaging investigations
    • Paris, France
      Saint Antoine
    Jul 23, 2019

    The Role of Microparticles as a Biomarker

    Withdrawn
    • Atypical Hemolytic Uremic Syndrome
    • +3 more
      • Rochester, New York
        University of Rochester Medical Center
      Feb 15, 2019

      Thrombotic Thrombocytopenic Purpura Trial in New York (Danazol)

      Terminated
      • Thrombotic Thrombocytopenic Purpura
      • New York, New York
        Mount Sinai St. Luke's-Roosevelt
      Dec 6, 2018

      TTP and aHUS in Complicated Pregnancies

      Unknown status
      • Thrombotic Thrombocytopenic Purpura
      • +7 more
      • ADAMTS 13, complement and angiogenic biomarkers
      • London, United Kingdom
        University College London Hospital
      Sep 21, 2018

      Thrombotic Thrombocytopenic Purpura Trial in Columbus (Cyclosporine, Prednisone)

      Completed
      • Thrombotic Thrombocytopenic Purpura
      • Columbus, Ohio
        Ohio State University
      Sep 20, 2017

      Thrombotic Thrombocytopenic Purpura Trial in Paris (rituximab)

      Completed
      • Thrombotic Thrombocytopenic Purpura
      • Paris, France
        Saint-Antoine Hospital, Hematology
      Feb 26, 2014

      Thrombotic Thrombocytopenic Purpura Trial in United States (Rituximab, Plasma exchange, Corticosteroids)

      Terminated
      • Thrombotic Thrombocytopenic Purpura
      • Birmingham, Alabama
      • +22 more
      Jul 18, 2013

      Biorepository for TMA(Thrombotic Microangiopathy)

      Terminated
      • Thrombotic Microangiopathy
      • +2 more
        • New Hyde Park, New York
          Schneider Chldren's Hospital
        Jun 18, 2013

        ADAMTS13 in Thrombotic Thrombocytopenic Purpura

        Completed
        • Thrombotic Thrombocytopenic Purpura
          • Clamart, France
            Hôpital Antoine Béclère
          Dec 11, 2012

          Thrombotic Thrombocytopenic Purpura Trial in New York (Rituximab)

          Withdrawn
          • Thrombotic Thrombocytopenic Purpura
          • New York, New York
            Weill Medical College of Cornell University/New York Presbyteria
          Nov 14, 2012

          Thrombotic Thrombocytopenic Purpura, Hemolytic Uremic Syndrome Trial in Canada (Rituximab)

          Unknown status
          • Thrombotic Thrombocytopenic Purpura
          • Hemolytic Uremic Syndrome
          • Calgary, Alberta, Canada
          • +10 more
          May 18, 2010

          Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura Trial in Worldwide (ARC 1779 Placebo, ARC1779 Injection)

          Terminated
          • Thrombotic Microangiopathy
          • Thrombotic Thrombocytopenic Purpura
          • ARC 1779 Placebo
          • ARC1779 Injection
          • Chicago, Illinois
          • +16 more
          Nov 24, 2009